For how we live.
4 articles published between March 18, 2026 and October 20, 2026.
A single-centre randomised trial found the Bergen 4-day treatment cut obsessive-compulsive symptoms far more than an unguided internet CBT programme, with 61% responding at three months versus 25%.
A network meta-analysis of 54 trials put behavioural and cognitive therapies ahead of the drugs on OCD symptoms. But most therapy trials also allowed antidepressants, hinting the two work best together.
A subculture built on ranking faces sits directly on top of a recognised, treatable mental illness. The distress, not the jawline, is the part the evidence says to take seriously.
Up to eight sessions of psilocybin, layered onto a small randomized comparison against an active placebo, produced a 73% response rate by the end of treatment. The trial was designed to test safety first.